Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma

Antigen peptides and adjuvants have been extensively investigated for cancer immunotherapy, and they are expected to elicit specific immune responses for cancer treatment. However, the anti-cancer efficacy of antigen peptide and adjuvant-based cancer vaccines has been limited due to the inefficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Li-Min, Liu, Lei, Liu, Rui, Du, Ya-Fei, Luo, Qian, Xu, Jia-Rui, Xie, Ying, Lu, Wan-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539931/
https://www.ncbi.nlm.nih.gov/pubmed/31060324
http://dx.doi.org/10.3390/ijms20092207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539931/
https://www.ncbi.nlm.nih.gov/pubmed/31060324
http://dx.doi.org/10.3390/ijms20092207

Ejemplares similares